TCT 2025 - Dr Nadira Hamid (Allina Health Minneapolis Heart Institute, Minneapolis, US) is joined by Dr Jonathan Schwartz (Sanger Heart and Vascular Institute, Charlotte, US) to discuss the lessons learned from the update of the TRILUMINATE Pivotal Trial (NCT03904147), investigating tricuspid TEER (transcatheter edge-to-edge repair) in 800+ patients with severe tricuspid regurgitation.

Findings at 30 days showed that TriClip was both safe and effective, with improvements in quality of life. Low rates of mortality, heart failure hospitalisations, bleeding, conduction disturbances and device mortality were observed.

For more content from TCT 2025 head to the Late-breaking Science Video Collection.

Recorded on-site at TCT Conference in San Francisco, 2025.
Editor: Yazmin Sadik, Jordan Rance, Mirjam Boros
Video Specialist: Tom Green, Mike Knight

Support: This is an independent interview produced by Transcatheter Academy.